Ghohestani R F, Nicolas J F, Rousselle P, Claudy A L
Department of Dermatology, Edouard Herriot Hospital, Lyon, France.
Arch Dermatol. 1997 Sep;133(9):1102-7.
To determine the diagnostic value of indirect immunofluorescence on sodium chloride-split skin (SSS) in differentiating the pemphigoid group of subepidermal autoimmune bullous dermatoses, including bullous pemphigoid (BP), cicatricial pemphigoid, and pemphigoid gestationis, from epidermolysis bullosa acquisita (EBA).
Serum samples were tested using immunofluorescence on SSS and immunoblot assay on epidermal and dermal extracts, a recombinant protein corresponding to the C-terminal end of the 230-kd BP antigen, and purified laminin-5.
An immunodermatology laboratory.
One hundred forty-two serum samples from patients with BP (n = 98), cicatricial pemphigoid (n = 23), pemphigoid gestationis (n = 10), EBA (n = 10), and anti-type IV collagen (n = 1).
Binding sites of serum to the epidermal and/or dermal sides of SSS were correlated with their antigenic specificities.
Epidermal staining on SSS was highly specific for pemphigoid. Alternatively, a poor correlation was found for the dermal-reacting serum samples and the diagnosis of EBA; of the 19 serum samples with dermal staining on SSS, only 10 reacted with the EBA antigen. The remaining serum samples were from patients with cicatricial pemphigoid having antibodies to the alpha 3 or beta 3 chains of laminin-5 (n = 5) or patients with BP having antibodies to the 180-kd BP antigen (n = 2). One sample recognized exclusively a 185-kd dermal antigen corresponding to type IV collagen. One more BP serum sample with dermal staining did not recognize any dermal or epidermal antigen.
In case of immunofluorescent dermal staining, the precise diagnosis should be confirmed by identification of the involved antigen, since it may reveal antibodies to laminin-5 or type XVII or IV collagen, in addition to the EBA antigen.
确定氯化钠分离皮肤(SSS)间接免疫荧光法在鉴别大疱性类天疱疮(BP)、瘢痕性类天疱疮、妊娠类天疱疮等表皮下自身免疫性大疱性皮肤病类天疱疮组与获得性大疱性表皮松解症(EBA)中的诊断价值。
血清样本采用SSS免疫荧光法以及表皮和真皮提取物免疫印迹法检测,检测对象包括对应230kd BP抗原C末端的重组蛋白和纯化的层粘连蛋白-5。
免疫皮肤病学实验室。
来自BP患者(n = 98)、瘢痕性类天疱疮患者(n = 23)、妊娠类天疱疮患者(n = 10)、EBA患者(n = 10)和抗IV型胶原患者(n = 1)的142份血清样本。
血清与SSS表皮和/或真皮侧的结合位点与其抗原特异性相关。
SSS上的表皮染色对类天疱疮具有高度特异性。另外,真皮反应性血清样本与EBA诊断之间的相关性较差;在19份SSS上有真皮染色的血清样本中,只有10份与EBA抗原发生反应。其余血清样本来自瘢痕性类天疱疮患者,其具有针对层粘连蛋白-5的α3或β3链的抗体(n = 5),或来自BP患者,其具有针对180kd BP抗原的抗体(n = 2)。一份样本仅识别对应IV型胶原的185kd真皮抗原。另一份有真皮染色的BP血清样本未识别任何真皮或表皮抗原。
在免疫荧光真皮染色的情况下,应通过鉴定所涉及的抗原来确认准确诊断,因为除EBA抗原外,还可能显示针对层粘连蛋白-5、XVII型或IV型胶原的抗体。